Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis
- PMID: 24369898
- DOI: 10.1016/j.molmed.2013.11.007
Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis
Abstract
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system. Current treatments are very effective in reducing the neuroinflammatory attack, but fail to significantly halt disease progression and associated loss of neuronal tissue. In recent years, it has become increasingly clear that dysfunctional mitochondria are important contributors to damage and loss of both axons and neurons. Observations in animal and histopathological studies suggest that infiltrating leukocytes and activated microglia play a central role in neuronal mitochondrial dysfunction. This review provides a comprehensive overview on the current knowledge regarding mitochondrial dysfunction in MS. Importantly, more insight into the cause and consequences of impaired mitochondrial function provide a basis for mitochondrial-targeted medicine to combat progressive MS.
Keywords: mitochondria; multiple sclerosis; neurodegeneration; neuroinflammation; oxidative stress.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Similar articles
-
Mitochondrial dysfunction in demyelinating diseases.Semin Pediatr Neurol. 2013 Sep;20(3):194-201. doi: 10.1016/j.spen.2013.09.001. Semin Pediatr Neurol. 2013. PMID: 24331361 Review.
-
Mitochondrial changes associated with demyelination: consequences for axonal integrity.Mitochondrion. 2012 Mar;12(2):173-9. doi: 10.1016/j.mito.2011.03.007. Epub 2011 Mar 23. Mitochondrion. 2012. PMID: 21406249 Review.
-
Multiple sclerosis as a neurodegenerative disease: pathology, mechanisms and therapeutic implications.Curr Opin Neurol. 2011 Jun;24(3):224-9. doi: 10.1097/WCO.0b013e328346056f. Curr Opin Neurol. 2011. PMID: 21455066 Review.
-
The role of mitochondria in axonal degeneration and tissue repair in MS.Mult Scler. 2012 Aug;18(8):1058-67. doi: 10.1177/1352458512452924. Epub 2012 Jun 21. Mult Scler. 2012. PMID: 22723572 Review.
-
Mitochondrial dysfunction plays a key role in progressive axonal loss in Multiple Sclerosis.Med Hypotheses. 2005;64(4):669-77. doi: 10.1016/j.mehy.2004.09.001. Med Hypotheses. 2005. PMID: 15694681
Cited by
-
Nrf2 Signaling in Sodium Azide-Treated Oligodendrocytes Restores Mitochondrial Functions.J Mol Neurosci. 2018 Oct;66(2):229-237. doi: 10.1007/s12031-018-1159-2. Epub 2018 Aug 23. J Mol Neurosci. 2018. PMID: 30140996
-
Contribution of normal aging to brain atrophy in MS.Neurol Neuroimmunol Neuroinflamm. 2019 Sep 25;6(6):e616. doi: 10.1212/NXI.0000000000000616. Print 2019 Nov. Neurol Neuroimmunol Neuroinflamm. 2019. PMID: 32330116 Free PMC article.
-
Selective Modulation of TNF-TNFRs Signaling: Insights for Multiple Sclerosis Treatment.Front Immunol. 2018 Apr 30;9:925. doi: 10.3389/fimmu.2018.00925. eCollection 2018. Front Immunol. 2018. PMID: 29760711 Free PMC article. Review.
-
Increased blood-brain barrier hyperpermeability coincides with mast cell activation early under cuprizone administration.PLoS One. 2020 Jun 8;15(6):e0234001. doi: 10.1371/journal.pone.0234001. eCollection 2020. PLoS One. 2020. PMID: 32511268 Free PMC article.
-
Rotenone remarkably attenuates oxidative stress, inflammation, and fibrosis in chronic obstructive uropathy.Mediators Inflamm. 2014;2014:670106. doi: 10.1155/2014/670106. Epub 2014 Jul 22. Mediators Inflamm. 2014. PMID: 25140114 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical